NIAID/DCR Technical and Administrative Management Services

The National Institutes of Health established a Master IDIQ with the National Institute of Allergy and Infectious Diseases (NIAID), Division of Clinical Research (DCR) on September 6, 2016, to rapidly deploy administrative and technical research support services for time-sensitive, high-priority global collaborative clinical research. Ordering closed on September 30, 2023, and the vehicle is no longer active for new task orders.

The vehicle carried a $750 million shared ceiling against which nine task orders were awarded between December 2016 and April 2019. All task orders were unrestricted (no set-aside applied). The combined potential value of awarded orders is $13 million, with $10.5 million obligated (81% utilization). Activity concentrated in the initial award period, with five orders in 2016, three in 2018, and one in 2019; no orders were issued in 2017, 2020, 2021, 2022, or 2023. The most recent task order was awarded on April 15, 2019.

Family Health International and PPD Development LP dominate the awarded base. Family Health International holds three orders valued at $6.1 million combined potential value. PPD Development LP holds two orders valued at $5.8 million combined potential value, including the largest single task order (awarded April 2019 to provide monitoring services for one Phase III clinical trial, with a ceiling of $5.758 million and ultimate completion on December 14, 2025). Social & Scientific Systems, Inc. holds two orders at $1 million combined. Westat and Deloitte Consulting each hold one order at $50 thousand each.

All nine task orders funded NIAID/DCR exclusively; no other agencies placed orders. Awarded work included clinical trial monitoring services, financial service center operations in Guinea and Liberia, and informatics technology support for the LA RED Network. Task orders employed cost-plus-fixed-fee, cost-plus-award-fee, and firm-fixed-price pricing models.

Since the vehicle's ordering period has expired and only $10.5 million of the $750 million ceiling was obligated, this IDIQ is not available for new task orders or contracting activity.

The National Institute of Allergy and Infectious Diseases (NIAID), Division of Clinical Research (DCR), rapidly deploys administrative and technical research support services and resources to meet the external demands placed on the NIAID to conduct time sensitive, high priority, global, collaborative clinical research critical to the mission of the NIAID and advancement of the National Institutes of Health (NIH) and Department of Health and Human Services (DHHS) Global Health Agendas. Fulfillment of this mission requires DCR to have the capacity to expeditiously facilitate collaborative clinical research both domestically and internationally.